Company intelligence / Profile preview

Celero Systems

Lincoln, Massachusetts, United Statescelerosystems.com ↗

Ownership: Private
Employees: ~6
Development stage: Preclinical

Overview

Celero Systems has developed an ingestible capsule-based system capable of monitoring cardiac and respiratory parameters from within the gastrointestinal tract. Clinical studies have demonstrated the tolerability of their modified Health-Dx™ capsule as well as its ability to measure respiration during polysomnography compared to standard sensors. The technology is positioned to detect opioid overdose events in real time and deliver medication when needed. No commercial launch or pivotal trial data yet.

Therapeutic areas: PulmonologyNeurology
Modalities: Device (specifically ingestible digital pill)Platform (digital health platform)
Industry: Physiological Monitoring

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed.

Beyond the preview

Go deeper on Celero Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Celero Systems.

Explore the full profile